دورية أكاديمية
Using the Right Criteria for MCAS.
| العنوان: | Using the Right Criteria for MCAS. |
|---|---|
| المؤلفون: | Gulen T; Department of Respiratory Medicine and Allergy, K85, Karolinska University Hospital Huddinge, Stockholm, SE-14186, Sweden. theo.gulen@ki.se.; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. theo.gulen@ki.se.; Clinical Lung and Allergy Research Unit, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. theo.gulen@ki.se.; Mastocytosis Centre Karolinska, Karolinska University Hospital Huddinge, Stockholm, Sweden. theo.gulen@ki.se. |
| المصدر: | Current allergy and asthma reports [Curr Allergy Asthma Rep] 2024 Feb; Vol. 24 (2), pp. 39-51. Date of Electronic Publication: 2024 Jan 20. |
| نوع المنشور: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Current Science Inc Country of Publication: United States NLM ID: 101096440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6315 (Electronic) Linking ISSN: 15297322 NLM ISO Abbreviation: Curr Allergy Asthma Rep Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Philadelphia, PA : Current Science Inc., c2001- |
| مواضيع طبية MeSH: | Mastocytosis* , Mast Cell Activation Syndrome*, Humans ; Tryptases ; Mast Cells ; Diagnosis, Differential |
| مستخلص: | Purpose of Review: The current article aims to provide a comprehensive update on diagnostic criteria for mast cell activation syndrome (MCAS), addressing challenges in diagnosing and classifying MCAS and its variants. Recent Findings: In recent years, there has been a significant increase in our knowledge regarding the underlying mechanisms responsible for the activation of mast cells (MCs) in various pathological conditions. Furthermore, a set of criteria and a classification for MCASs have been established. MCAS is characterized by the presence of typical clinical symptoms, a substantial elevation in serum tryptase levels during an attack compared to the patient's baseline tryptase levels, and a response to MC mediator-targeting therapy. In this report, a thorough examination was conducted on the contemporary literature relating to MCAS, with a focus on comparing the specificity, sensitivity, and robustness of MCAS-related parameters within proposals for diagnosing and classifying MCAS and its variants. Moreover, the significance of employing specific consensus criteria in the assessment and categorization of MCAS in individual patients was underscored, due to the escalating occurrence of patients receiving a misdiagnosis of MCAS based on nonspecific criteria. (© 2024. The Author(s).) |
| References: | J Allergy Clin Immunol. 2022 Jun;149(6):1912-1918. (PMID: 35487307) Allergy. 2020 Jan;75(1):169-177. (PMID: 31306487) N Engl J Med. 1987 Jun 25;316(26):1622-6. (PMID: 3295549) Clin Exp Allergy. 2009 Jan;39(1):72-80. (PMID: 19128354) J Allergy Clin Immunol Pract. 2019 Apr;7(4):1109-1114. (PMID: 30961836) Am J Pathol. 2010 Jan;176(1):227-37. (PMID: 20008150) Clin Exp Allergy. 2014 Jan;44(1):121-9. (PMID: 24164252) Am J Emerg Med. 2016 Feb;34(2):174-9. (PMID: 26542795) Eur J Clin Invest. 2008 Dec;38(12):953-8. (PMID: 19021721) Blood. 2007 Oct 1;110(7):2331-3. (PMID: 17638853) N Engl J Med. 2004 Feb 12;350(7):735-6. (PMID: 14960756) Curr Opin Allergy Clin Immunol. 2017 Aug;17(4):295-303. (PMID: 28570344) Annu Rev Immunol. 2005;23:749-86. (PMID: 15771585) Chem Immunol Allergy. 2010;95:45-66. (PMID: 20519881) J Allergy Clin Immunol. 2013 May;131(5):1429-31.e1. (PMID: 23219169) J Allergy Clin Immunol. 2021 Feb;147(2):622-632. (PMID: 32717252) J Allergy Clin Immunol Pract. 2021 Nov;9(11):3918-3928. (PMID: 34166845) J Allergy Clin Immunol. 2010 Dec;126(6):1099-104.e4. (PMID: 21035176) Dtsch Arztebl Int. 2014 May 23;111(21):367-75. (PMID: 24939374) Nat Immunol. 2011 Oct 19;12(11):1035-44. (PMID: 22012443) J Am Acad Dermatol. 2006 Dec;55(6):1075-7. (PMID: 17110222) J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1169-1178. (PMID: 28888247) Cancers (Basel). 2022 Aug 16;14(16):. (PMID: 36010937) J Allergy Clin Immunol. 2010 Jun;125(6):1269-1278.e2. (PMID: 20434205) Allergy. 2017 Dec;72(12):2031-2034. (PMID: 28609557) Br J Haematol. 2014 Aug;166(4):521-8. (PMID: 24761987) J Allergy Clin Immunol. 2016 Apr;137(4):1128-1137.e1. (PMID: 26806049) N Engl J Med. 2015 Jul 9;373(2):163-72. (PMID: 26154789) J Allergy Clin Immunol. 2018 Jan;141(1):180-188.e3. (PMID: 28629749) Immunol Allergy Clin North Am. 2022 Feb;42(1):45-63. (PMID: 34823750) Clin Exp Allergy. 2014 Sep;44(9):1179-87. (PMID: 25039926) J Allergy Clin Immunol Pract. 2019 Apr;7(4):1125-1133.e1. (PMID: 30737190) J Allergy Clin Immunol Pract. 2023 Aug;11(8):2542-2546. (PMID: 36863614) J Allergy Clin Immunol. 2009 Oct;124(4):639-46; quiz 647-8. (PMID: 19815110) Leuk Res. 2001 Jul;25(7):553-62. (PMID: 11377680) J Allergy Clin Immunol. 2014 May;133(5):1471-4. (PMID: 24472624) Immunol Allergy Clin North Am. 2006 Aug;26(3):451-63. (PMID: 16931288) Int J Mol Sci. 2020 Jan 11;21(2):. (PMID: 31940755) J Allergy Clin Immunol. 1994 May;93(5):817-24. (PMID: 8182221) Int Arch Allergy Immunol. 2019;180(1):44-51. (PMID: 31256161) J Allergy Clin Immunol. 2013 Jan;131(1):144-9. (PMID: 23040367) Rev Endocr Metab Disord. 2016 Sep;17(3):373-380. (PMID: 27873108) Immunopharmacol Immunotoxicol. 2012 Aug;34(4):679-85. (PMID: 22268664) Eur J Immunol. 2010 Jul;40(7):1843-51. (PMID: 20583030) Ann Allergy Asthma Immunol. 2013 Sep;111(3):155-62. (PMID: 23987187) Compr Ther. 2005 Spring;31(1):59-71. (PMID: 15793325) Int J Mol Sci. 2021 Feb 28;22(5):. (PMID: 33671092) J Histochem Cytochem. 2014 Oct;62(10):698-738. (PMID: 25062998) Clin Med Res. 2018 Jun;16(1-2):16-28. (PMID: 29650525) Allergy. 2015 Oct;70(10):1230-8. (PMID: 26095439) J Allergy Clin Immunol Pract. 2020 Nov - Dec;8(10):3549-3556. (PMID: 32553831) Immunol Allergy Clin North Am. 2023 Nov;43(4):681-698. (PMID: 37758406) Thorax. 2004 Jun;59(6):453-5. (PMID: 15170020) N Engl J Med. 1980 Dec 11;303(24):1400-4. (PMID: 6107852) Diagnostics (Basel). 2023 Oct 25;13(21):. (PMID: 37958203) Adv Shock Res. 1982;8:145-52. (PMID: 7136941) Blood. 2021 Jan 14;137(2):238-247. (PMID: 32777817) J Allergy Clin Immunol. 2019 Oct;144(4):883-896. (PMID: 31476322) J Allergy Clin Immunol. 2020 Aug;146(2):356-366.e4. (PMID: 32437738) Arq Bras Endocrinol Metabol. 2005 Oct;49(5):850-60. (PMID: 16444370) Lancet. 2014 May 3;383(9928):1608. (PMID: 24792857) Clin Exp Allergy. 2017 Jul;47(7):909-917. (PMID: 28258965) J Allergy Clin Immunol. 2014 Feb;133(2):461-7. (PMID: 24144575) Int Arch Allergy Immunol. 1995 Oct;108(2):158-64. (PMID: 7549503) J Intern Med. 2016 Mar;279(3):211-28. (PMID: 26347286) J Allergy Clin Immunol. 2008 Dec;122(6):1161-5. (PMID: 18992928) Allergy. 2018 Jan;73(1):230-238. (PMID: 28662309) Cancers (Basel). 2021 Dec 20;13(24):. (PMID: 34944999) Am J Clin Dermatol. 2015 Oct;16(5):425-30. (PMID: 26242228) J Clin Immunol. 1994 May;14(3):190-204. (PMID: 7929694) J Allergy Clin Immunol Pract. 2020 Jan;8(1):426. (PMID: 31950910) N Engl J Med. 2008 Jan 3;358(1):28-35. (PMID: 18172172) J Allergy Clin Immunol. 2016 Jan;137(1):312-314.e7. (PMID: 26292777) J Bone Miner Res. 2005 Apr;20(4):672-81. (PMID: 15765187) Crit Rev Immunol. 2011;31(6):475-529. (PMID: 22321108) J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1220-1226. (PMID: 27406968) Theranostics. 2020 Aug 29;10(23):10743-10768. (PMID: 32929378) Hemasphere. 2021 Oct 13;5(11):e646. (PMID: 34901755) N Engl J Med. 2016 Jun 30;374(26):2530-41. (PMID: 27355533) J Allergy Clin Immunol. 2006 Apr;117(4):950-1. (PMID: 16630958) Immunol Allergy Clin North Am. 2006 Aug;26(3):465-85. (PMID: 16931289) Ann Emerg Med. 2006 Apr;47(4):373-80. (PMID: 16546624) Prostaglandins Other Lipid Mediat. 2010 Jun;92(1-4):73-6. (PMID: 20380889) Allergy. 2012 May;67(5):683-90. (PMID: 22435702) J Allergy Clin Immunol Pract. 2020 Sep;8(8):2533-2541. (PMID: 32142966) Agents Actions. 1982 Apr;12(1-2):29-31. (PMID: 7080964) Int Arch Allergy Immunol. 2008;147(4):338-43. (PMID: 18622141) Allergy. 2008 Feb;63(2):226-32. (PMID: 18186813) J Allergy Clin Immunol. 2022 Feb;149(2):728-735.e2. (PMID: 34174297) J Immunol. 2000 Mar 1;164(5):2277-80. (PMID: 10679060) Nat Genet. 2016 Dec;48(12):1564-1569. (PMID: 27749843) Curr Allergy Asthma Rep. 2021 Feb 9;21(2):11. (PMID: 33560495) Immunol Allergy Clin North Am. 2022 Feb;42(1):1-11. (PMID: 34823740) J Allergy Clin Immunol Pract. 2023 Dec 4;:. (PMID: 38056692) Allergy. 2013 Nov;68(11):1353-61. (PMID: 24117770) Front Horm Res. 2015;44:40-57. (PMID: 26303703) Curr Opin Allergy Clin Immunol. 2008 Aug;8(4):310-5. (PMID: 18596587) J Allergy Clin Immunol Pract. 2022 Aug;10(8):1941-1950. (PMID: 35623575) J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):687-689.e4. (PMID: 29033257) Int Arch Allergy Immunol. 2007;142(2):158-64. (PMID: 17057414) J Allergy Clin Immunol. 2012 Mar;129(3):748-52. (PMID: 22051698) Chem Immunol Allergy. 2005;87:43-58. (PMID: 16107762) J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):775-8. (PMID: 25439370) N Engl J Med. 1983 Dec 29;309(26):1603-5. (PMID: 6646186) J Allergy Clin Immunol. 1992 Jul;90(1):110-8. (PMID: 1629497) Immunol Allergy Clin North Am. 2023 Nov;43(4):743-750. (PMID: 37758410) J Immunol. 2011 Dec 15;187(12):6518-26. (PMID: 22102725) Chem Immunol Allergy. 2010;95:12-21. (PMID: 20519879) Am J Med. 2014 Jan;127(1 Suppl):S6-11. (PMID: 24384138) PLoS One. 2015 Apr 24;10(4):e0124912. (PMID: 25909362) |
| فهرسة مساهمة: | Keywords: Anaphylaxis; Hereditary alpha-tryptasemia; MCAS; Mast cell activation; Mastocytosis; Tryptase |
| المشرفين على المادة: | EC 3.4.21.59 (Tryptases) |
| تواريخ الأحداث: | Date Created: 20240119 Date Completed: 20240215 Latest Revision: 20240524 |
| رمز التحديث: | 20240525 |
| مُعرف محوري في PubMed: | PMC10866766 |
| DOI: | 10.1007/s11882-024-01126-0 |
| PMID: | 38243020 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1534-6315 |
|---|---|
| DOI: | 10.1007/s11882-024-01126-0 |